New NIAID Funding Opportunity Announcement: Partnerships for Countermeasures Against Select Pathogens (R01)

Purpose: To solicit research applications for milestone-driven projects focused on preclinical development of lead candidate countermeasures (therapeutics, vaccines and related technologies, or diagnostics) against select NIAID Emerging Infectious Diseases/Pathogens.

Application Due Date: October 3, 2016

Budget: Direct costs of up to $750,000 per year may be requested. Applicants may also request up to an additional $300,000 in the first year of the award for major equipment to ensure that research objectives can be met and biohazards can be contained, totaling $1,050,000 direct costs.

Total Award: ~4,000,000 over 5 years

To discuss this opportunity or to learn about other non-dilutive funding that may be relevant to your organization, send us a note and we’ll get in touch with you directly!